COMMUNIQUÉS West-GlobeNewswire

PHOTOS: Aleafia Health Completes Planting of Canada’s First Legal Outdoor Cannabis Crop
13/06/2019
• 13,000 Cannabis Plants now Growing at Company’s Outdoor Grow Facility • Harvest of First Outdoor Crop Planned for Q3 2019 • Planting of Crop Completed Less Than One Week Following Health Canada Approval TORONTO, June [...]
Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program
13/06/2019
Company announcement – No. 20 / 2019 Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program Copenhagen, June 13, 2019 – Zealand Pharma A/S (“Zealand”) ( [...]
Crown Bioscience annonce quatre nouveaux modèles précliniques de la NASH en développement
13/06/2019
- Réaffirme son engagement pour la découverte de médicaments contre la NASH - SAN DIEGO, 13 juin 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, société mondiale de services de découverte et de développement de médicaments [...]
Oncology Venture increases its ownership in dovitinib
13/06/2019
Press release Hoersholm, Denmark, June 13, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) has acquired an additional 8% ownership in the dovitinib project from Sass & Larsen Aps. Following the [...]
ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
13/06/2019
Amsterdam, The Netherlands – 13 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that it has resumed negotiations with Polski Bank Komórek Macierzystych S.A. (WSE: PBKM, “PBKM”) regarding the proposed [...]
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, meets primary endpoints in Phase IIa study in patients undergoing a lumbar spinal fusion procedure
13/06/2019
Regulated Information – Inside Information Treatment with ALLOB resulted in significant clinical and radiological improvements Treatment with ALLOB was well-tolerated, consistent with previous reported results At 12 [...]
Bone Therapeutics SA : ALLOB, le produit de thérapie cellulaire allogénique de Bone Therapeutics, valide les principaux critères d’évaluation de l’étude de phase IIa chez des patients ayant subi une procédure de fusion vertébrale
13/06/2019
Information règlementaire – Information confidentielle Le traitement par ALLOB induit des améliorations significatives tant au niveau clinique que radiologique Bon profil de tolérance d’ALLOB, cohérent avec les [...]
Efficacy and safety data with Idorsia's dual orexin receptor antagonist presented at SLEEP 2019 in San Antonio
13/06/2019
Allschwil, Switzerland – June 13, 2019 Idorsia Ltd (SIX: IDIA) today announced that efficacy and safety data from two Phase 2 studies of ACT‑541468, Idorsia's dual orexin receptor antagonist, for the treatment of adult [...]
HEXO Corp reports third quarter 2019 financial results
13/06/2019
Key highlights of third quarter of 2019 fiscal year HEXO remains on-track ramping up to $400 million net revenue in fiscal 2020 and to double net revenue in Q4 fiscal 2019 Entered a syndicated credit facility with CIBC [...]
HEXO Corp annonce ses résultats financiers pour le troisième trimestre de 2019
13/06/2019
Faits marquants du troisième trimestre de l’exercice 2019 HEXO poursuit ses efforts visant à atteindre des revenus nets de 400 millions de dollars à l’exercice 2020 et à multiplier par deux le montant de ses revenus [...]
MediciNova to Present at the JMP Securities Life Sciences Conference
13/06/2019
LA JOLLA, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Align Technology Launches the iTero Element® Foundation Intraoral Scanner With Restorative Software
12/06/2019
Restorative only scanner provides dentists with new option on path to digital practice transformation SAN JOSE, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today the [...]
ReWalk Robotics Announces Closing of Registered Direct Offering for $5.0 Million Priced At-the-Market
12/06/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing of its previously announced registered [...]
Zomedica to Present at Raymond James Life Sciences and MedTech Conference
12/06/2019
ANN ARBOR, Mich., June 12, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the [...]
iCAD Announces Proposed Public Offering of Common Stock
12/06/2019
NASHUA, N.H., June 12, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it has commenced [...]
Cerecor Appoints Keith Schmidt to its Board of Directors
12/06/2019
ROCKVILLE, Md., June 12, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
Nuvectra® to Participate in Two Upcoming Investor Conferences
12/06/2019
PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming [...]
Cytokinetics to Present at the JMP Securities Life Sciences Conference
12/06/2019
SOUTH SAN FRANCISCO, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate [...]
Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin
12/06/2019
OCALA, Fla., June 12, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc. announced today that the first patient has been treated in the Phase 2 recurrent ovarian cancer program at the University [...]

Pages